Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

25.11
-0.6200-2.41%
Post-market: 24.90-0.2097-0.84%19:59 EDT
Volume:16.05M
Turnover:401.98M
Market Cap:9.71B
PE:-2.71
High:25.77
Open:25.20
Low:23.76
Close:25.73
Loading ...

Company Profile

Company Name:
Moderna, Inc.
Exchange:
NASDAQ
Establishment Date:
2010
Employees:
5800
Office Location:
325 Binney Street,Cambridge,Massachusetts,United States
Zip Code:
02142
Fax:
- -
Introduction:
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Directors

Name
Position
Noubar B. Afeyan
Chairman
Stephane Bancel
Director,Chief Executive Officer
Abbas Hussain
Independent Director
David M. Rubenstein
Independent Director
Elizabeth Nabel
Independent Director
Elizabeth Tallett
Independent Director
Francois Nader
Independent Director
Paul Sagan
Independent Director
Sandra Horning
Independent Director

Shareholders

Name
Position
Stephane Bancel
Director,Chief Executive Officer
James Mock
Chief Financial Officer
Jacqueline Miller
Chief Medical Officer
Jerh Collins
Chief Technical Operations and Quality Officer
Kate Cronin
Chief Brand Officer
Rose Loughlin
Executive Vice President, Research
Shannon Thyme Klinger
Chief Legal Officer and Corporate Secretary
Stephen Hoge
President
Tracey Franklin
Chief People and Digital Technology Officer